MountzJMStafford-SchuckK: Thallium-201 tumor/cardiac ratio estimation of residual astrocytoma. J Neurosurg, 68: 705–709, 1988.
7.
LiljaALundquistH: Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions. Acta Radiologica, 30: 121–128, 1989.
8.
ColemanREHoffmanJM: Clinical application of PET for the evaluation of brain tumors. J Nucl Med, 32: 616–622, 1990.
9.
GlantzMHoffmanJ: Identification of early recurrence of primary central nervous system tumors by 18F-Fluorodeoxyglucose positron emission tomography. Ann Neurol, 29: 347–355, 1991.
10.
WalkPEDillonWP: Radiation injury of the brain. Am J Neuroradiol, 12: 45–62, 1991.
11.
DoyleWBudingerTF: Differentiation of cerebral radiation necrosis from tumor recurrence by (18F) FDG and 82Rb positron emission tomography. J Comput Assist Tomography, 11: 563–570, 1987.
12.
JanusTKimE: Use of 18F-Fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Ann Neurol, 33: 540–548, 1993.
13.
KaplanWDTakvorianT: Thallium-201 brain tumor imaging: A comparative study with pathologic correlation. J Nucl Med, 28: 47–2, 1987.
14.
CarvalhoASchwartzR: Detection of recurrent gliomas with quantitative Thallium-201/technetium-99m HM-PAO single-photon emission computerized tomography. J Neurosurg, 77: 565–570, 1992.
15.
CairncrossGMcDonaldD: Steroid-induced CT changes in patients with recurrent malignant glioma. Neurology, 38: 724–726, 1988.